EX-99.A 3 h12204exv99wa.txt JOINT FILING AGREEMENT EXHIBIT A JOINT FILING AGREEMENT Each of the undersigned agrees that (i) the statement on Schedule 13D relating to the ordinary shares of Cell Therapeutics, Inc., has been adopted and filed on behalf of each of them, (ii) all future amendments to such statement on Schedule 13D will, unless written notice to the contrary is delivered as described below, be jointly filed on behalf of each of them, and (iii) the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934 apply to each of them. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13D as to any of the undersigned upon such person giving written notice thereof to each of the other persons signature hereto, at the principal office thereof. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Date: January 26, 2004 ESSEX WOODLANDS HEALTH VENTURES IV, LP By: Essex Woodlands Health Ventures IV, LLC /s/ Martin P. Sutter ------------------------------------------- Name: Martin P. Sutter Title: Managing Director ESSEX WOODLANDS HEALTH VENTURES IV, LLC /s/ Martin P. Sutter ---------------------------------------------- Name: Martin P. Sutter Title: Managing Director /s/ James L. Currie ---------------------------------------------- Name: James L. Currie /s/ Martin P. Sutter ---------------------------------------------- Name: Martin P. Sutter /s/ Immanuel Thangaraj ---------------------------------------------- Name: Immanuel Thangaraj